Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
Fiche publication
Date publication
juin 2015
Journal
American journal of clinical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MERROUCHE Yacine
Tous les auteurs :
Pacaut C, Bourmaud A, Rivoirard R, Moriceau G, Guy JB, Collard O, Bosacki C, Jacquin JP, Levy A, Chauleur C, Magné N, Merrouche Y
Lien Pubmed
Résumé
The aim of this study was to assess the outcome and the prognosis factors of uterine and ovarian carcinosarcomas.
Mots clés
Adult, Aged, Aged, 80 and over, Carcinosarcoma, mortality, Chemoradiotherapy, Adjuvant, Chemotherapy, Adjuvant, Disease-Free Survival, Female, Follow-Up Studies, Humans, Hysterectomy, Lymph Node Excision, Middle Aged, Neoplasm Staging, Ovarian Neoplasms, mortality, Ovariectomy, Radiotherapy, Adjuvant, Retrospective Studies, Salpingectomy, Survival Rate, Treatment Outcome, Uterine Neoplasms, mortality
Référence
Am. J. Clin. Oncol.. 2015 Jun;38(3):272-7